Page 2 - Biomedical Data Science News Today

In a study published in May, James Zou, a professor of Biomedical Data Science at Stanford University, found that multiple artificial intelligence (A.I.)…

13.11.2023 - Management intends to provide an update on its zotatifin clinical development program in estrogen receptor-positive (ER+) metastatic breast cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium (SABCS) Topline results from Phase 2b KICKSTART ...

SHREVEPORT, La. – A biomedical researcher can’t just wake up one day and decide to “do science.”

A study released on Friday shows that though AI may bring some technological advantages to the table for healthcare, it could also perpetuate racist beliefs.

When <em>ANP32A</em> gene-edited chickens were exposed to a normal dose of the H9N2-UDL strain of avian influenza virus, nine out of 10 birds remained uninfected.

Philippine Canadian Inquirer New noninvasive RNA tests could help identify at-risk pregnancies Health

/PRNewswire/ -- Imagine a few roughly cut slices of bread on a plate. With just those slices, could you picture, in fine detail, the loaf they came from? Now,...

A new Yale study has identified a way to tame the self-destructive tendencies of certain killer T cells that are used to treat cancer.

In a promising form of immunotherapy known as CAR T-cell (chimeric antigen receptor) therapy, the patient’s T cells are engineered to better recognize and attack antigens on the surface of cancer cells. In treatments currently approved for use in battling lymphoma and leukemia, however, the therapy has a drawback: Amidst the cancer-killing frenzy, many engineered T cells become tainted with the remnants of cancer antigens, which causes them to turn on other T cells. This eventually depletes th...

In a promising form of immunotherapy known as CAR T-cell (chimeric antigen receptor) therapy, the patient's T cells are engineered to better recognize and attack antigens on the surface of cancer cells.